Insider Trading & SAST disclosures for Alivus Life Sciences Ltd.
The latest disclosure under SEBI Prohibition of Insider Trading regulations was made by
Glenmark Pharmaceuticals Limited in Alivus Life Sciences Ltd. where Disposal of 9,609,571
Equity Shares done at an average price of Rs. 830.7
was reported to the exchange on July 15, 2024.
The latest disclosures under SEBI SAST(Substantial Acquisition of Shares and Takeovers) Regulations, 2011 transaction was made by
Glenmark Pharmaceuticals Ltd in Alivus Life Sciences Ltd. where Non disposal undertaking of 9,609,571
shares done
was reported to the exchange on July 15, 2024.
Insider trades are disclosures under SEBI (Prohibition of Insider Trading) Regulations, 2015 ([Regulation 7 (2) with 6(2)] made by corporate insiders: promoters, officers, directors, employees and large shareholders who are buying and selling stock in their own companies.
| Client Name |
Client Category |
Action* |
Reported To/By Exchange |
Quantity |
Post Transaction Holding |
Traded % |
Avg. Price |
Value |
Period |
Regulation (Insider/SAST) |
Security Type |
Mode |
|
Glenmark Pharmaceuticals Limited
|
Promoter |
Disposal |
15 Jul 2024 |
9,609,571 |
0
(0%)
|
7.84%
|
830.7 |
7,983,000,234
|
11 Jul 2024
12 Jul 2024 |
Insider Trading |
Equity Shares |
Others |
|
Glenn Mario Saldanha
|
Promoter Group |
Disposal |
15 Jul 2024 |
7,800 |
0
(0%)
|
0.01%
|
829.6 |
6,471,076
|
11 Jul 2024
12 Jul 2024 |
Insider Trading |
Equity Shares |
Others |
|
Glenmark Pharmaceuticals Ltd
|
Promoter |
Non disposal undertaking |
17 Jul 2024 |
9,609,571 |
0
|
-
|
|
-
|
04 Jul 2024
04 Jul 2024 |
SAST (Reg31) |
- |
Release |
|
Glenmark Pharmaceuticals Ltd
|
Promoter |
Disposal |
22 Jul 2024 |
9,609,571 |
-
|
7.84%
|
|
-
|
11 Jul 2024
12 Jul 2024 |
SAST (29(2)) |
- |
Offer For Sale |
|
Nirma Limited
|
Promoter |
Acquisition |
13 Mar 2024 |
24,505,435 |
91,896,285
(75%)
|
20.00%
|
598.6 |
14,668,764,063
|
12 Mar 2024
12 Mar 2024 |
Insider Trading |
Equity Shares |
Off Market |
|
Glenmark Pharmaceuticals Limited
|
Promoter |
Disposal |
13 Mar 2024 |
24,505,435 |
9,609,571
(7.84%)
|
20.00%
|
598.0 |
14,654,095,299
|
12 Mar 2024
12 Mar 2024 |
Insider Trading |
Equity Shares |
Off Market |
|
Nirma Ltd
|
Promoter |
Acquisition |
19 Mar 2024 |
24,505,435 |
91,896,285
(75%)
|
20%
|
|
-
|
12 Mar 2024
12 Mar 2024 |
SAST (29(2)) |
- |
Off Market |
|
Glenmark Pharmaceuticals Ltd
|
Promoter |
Disposal |
19 Mar 2024 |
24,505,435 |
9,609,571
(7.84%)
|
20%
|
|
-
|
12 Mar 2024
12 Mar 2024 |
SAST (29(2)) |
- |
Off Market |
|
Glenmark Pharmaceuticals Ltd
|
Promoter |
Pledge |
24 Dec 2024 |
24,505,435 |
9,609,571
|
20%
|
|
-
|
12 Mar 2024
12 Mar 2024 |
SAST (Reg31) |
- |
Release |
|
Glenmark Pharmaceuticals Limited
|
Promoter |
Disposal |
07 Mar 2024 |
67,389,944 |
34,115,006
(27.84%)
|
55.00%
|
598.0 |
40,298,765,727
|
06 Mar 2024
06 Mar 2024 |
Insider Trading |
Equity Shares |
Off Market |
|
Glenmark Pharmaceuticals Ltd
|
Promoter |
Disposal |
14 Mar 2024 |
67,389,944 |
34,115,006
(27.84%)
|
55%
|
|
-
|
06 Mar 2024
06 Mar 2024 |
SAST (29(2)) |
- |
Off Market |
|
Nirma Ltd
|
Promoter |
Acquisition |
14 Mar 2024 |
67,390,850 |
67,390,850
(55%)
|
55%
|
|
-
|
05 Mar 2024
06 Mar 2024 |
SAST (29(1)) |
- |
Off Market |
|
Glenmark Pharmaceuticals Limited
|
Promoter |
Pledge |
25 Sep 2023 |
9,609,571 |
101,504,950
(82.84%)
|
7.84%
|
615 |
5,909,886,165
|
21 Sep 2023
21 Sep 2023 |
Insider Trading |
Equity Shares |
Others |
|
GLENN SALDANHA
|
Promoter Group |
Acquisition |
17 Nov 2021 |
295 |
295
(0%)
|
0.00%
|
640.8 |
189,026
|
15 Nov 2021
15 Nov 2021 |
Insider Trading |
Equity Shares |
Market Purchase |
|
GLENN SALDANHA
|
Promoter Group |
Acquisition |
17 Nov 2021 |
7,505 |
7,800
(0%)
|
0.01%
|
643.2 |
4,827,124
|
16 Nov 2021
16 Nov 2021 |
Insider Trading |
Equity Shares |
Market Purchase |
*Actions covered:
Acquisition (Buy): Purchase of shares
Disposal (Sell): Sale of shares
Pledge: Shares being used by promoters as collateral for loans. Usually a negative signal.
Revoke: When shares are released from a pledge. Usually a positive signal.
Invoke: When pledged shares are invoked by companies/banks who have provided the collateral, which may result in acquisition of stake in the company. Usually a negative signal.
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Kind of transaction Mode: Public rights/ preferential offer / off market / inter-se transfer/ Market Sale
Data as reported to BSE and NSE
Insider trading data is from Disclosure under SEBI (Prohibition of Insider Trading) Regulations, 2015.